These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 28662398)

  • 1. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
    Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
    Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
    Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
    Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.
    Izquierdo-Garcia D; Davies JR; Graves MJ; Rudd JH; Gillard JH; Weissberg PL; Fryer TD; Warburton EA
    Stroke; 2009 Jan; 40(1):86-93. PubMed ID: 18927453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.
    Metz S; Beer AJ; Settles M; Pelisek J; Botnar RM; Rummeny EJ; Heider P
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):901-12. PubMed ID: 20972832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
    Tang TY; Howarth SP; Miller SR; Graves MJ; Patterson AJ; U-King-Im JM; Li ZY; Walsh SR; Brown AP; Kirkpatrick PJ; Warburton EA; Hayes PD; Varty K; Boyle JR; Gaunt ME; Zalewski A; Gillard JH
    J Am Coll Cardiol; 2009 Jun; 53(22):2039-50. PubMed ID: 19477353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques in patients with asymptomatic carotid stenosis undergoing coronary artery bypass grafting: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study.
    Tang TY; Howarth SP; Miller SR; Graves MJ; U-King-Im JM; Li ZY; Walsh SR; Hayes PD; Varty K; Gillard JH
    Eur J Vasc Endovasc Surg; 2008 Apr; 35(4):392-8. PubMed ID: 18171628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T.
    Stirrat CG; Alam SR; MacGillivray TJ; Gray CD; Forsythe R; Dweck MR; Payne JR; Prasad SK; Petrie MC; Gardner RS; Mirsadraee S; Henriksen PA; Newby DE; Semple SI
    J Cardiovasc Magn Reson; 2016 Jul; 18(1):46. PubMed ID: 27465647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI.
    Tang T; Howarth SP; Miller SR; Trivedi R; Graves MJ; King-Im JU; Li ZY; Brown AP; Kirkpatrick PJ; Gaunt ME; Gillard JH
    Stroke; 2006 Sep; 37(9):2266-70. PubMed ID: 16917091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis.
    Tang TY; Moustafa RR; Howarth SP; Walsh SR; Boyle JR; Li ZY; Baron JC; Gillard JH; Warburton EA
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):53-5. PubMed ID: 18396074
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Vesey AT; Jenkins WS; Irkle A; Moss A; Sng G; Forsythe RO; Clark T; Roberts G; Fletcher A; Lucatelli C; Rudd JH; Davenport AP; Mills NL; Al-Shahi Salman R; Dennis M; Whiteley WN; van Beek EJ; Dweck MR; Newby DE
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):e004976. PubMed ID: 28292859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms.
    McBride OM; Joshi NV; Robson JM; MacGillivray TJ; Gray CD; Fletcher AM; Dweck MR; van Beek EJ; Rudd JH; Newby DE; Semple SI
    Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):518-26. PubMed ID: 26919936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.
    Brinjikji W; Huston J; Rabinstein AA; Kim GM; Lerman A; Lanzino G
    J Neurosurg; 2016 Jan; 124(1):27-42. PubMed ID: 26230478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT.
    Cyran CC; Sourbron S; Bochmann K; Habs M; Pfefferkorn T; Rominger A; Raya JG; Reiser MF; Dichgans M; Nikolaou K; Hacker M; Saam T
    Invest Radiol; 2011 Sep; 46(9):594-9. PubMed ID: 21577125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Johnsrud K; Skagen K; Seierstad T; Skjelland M; Russell D; Revheim ME
    J Nucl Cardiol; 2019 Jun; 26(3):883-893. PubMed ID: 29209949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.
    Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging.
    Kwee RM; Teule GJ; van Oostenbrugge RJ; Mess WH; Prins MH; van der Geest RJ; Ter Berg JW; Franke CL; Korten AG; Meems BJ; Hofman PA; van Engelshoven JM; Wildberger JE; Kooi ME
    Stroke; 2009 Dec; 40(12):3718-24. PubMed ID: 19875738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.